BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15319839)

  • 1. [Xenon - noble gas with organprotective properties].
    Preckel B; Weber N; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Aug; 39(8):456-62. PubMed ID: 15319839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on inhalational anaesthetics.
    De Hert SG; Preckel B; Schlack WS
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):491-5. PubMed ID: 19369864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial protection by volatile anesthetics].
    Preckel B; Müllenheim J; Schlack W
    Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon.
    Abraini JH; David HN; Lemaire M
    Ann N Y Acad Sci; 2005 Aug; 1053():289-300. PubMed ID: 16179534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?
    Minguet G; Joris J; Lamy M
    Eur J Anaesthesiol; 2007 Sep; 24(9):733-45. PubMed ID: 17555610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Xenon anaesthesia--clinical characteristics, benefits and disadvantages and fields of application].
    Höcker J; Grünewald M; Bein B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Jun; 47(6):374-80. PubMed ID: 22744851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.
    Rajakumaraswamy N; Ma D; Hossain M; Sanders RD; Franks NP; Maze M
    Neurosci Lett; 2006 Dec; 409(2):128-33. PubMed ID: 17052852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.
    Weber NC; Toma O; Damla H; Wolter JI; Schlack W; Preckel B
    Eur J Pharmacol; 2006 Jun; 539(1-2):1-9. PubMed ID: 16716295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenon as an anesthetic agent.
    Jordan BD; Wright EL
    AANA J; 2010 Oct; 78(5):387-92. PubMed ID: 21067086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concept of anaesthetic-induced cardioprotection: mechanisms of action.
    Weber NC; Schlack W
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):429-43. PubMed ID: 16013692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflurane and other commonly used anaesthetics do not protect the isolated buffer perfused mouse heart from ischemia-reperfusion injury.
    Galagudza M; Vaage J; Valen G
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):315-9. PubMed ID: 16620294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain and spinal cord preconditioning for the protection against ischemic injury].
    Matsumoto M; Ishida K; Sakabe T
    Masui; 2007 Mar; 56(3):285-97. PubMed ID: 17366916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How xenon works: neuro and cardioprotection mechanisms].
    Morais R; Andrade L; Lourenço A; Tavares J
    Acta Med Port; 2014; 27(2):259-65. PubMed ID: 24813496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway.
    Weber NC; Toma O; Wolter JI; Wirthle NM; Schlack W; Preckel B
    Br J Pharmacol; 2005 Oct; 146(3):445-55. PubMed ID: 16086037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.